To conclude, we provide in vivo evidence for neuroinflammation in FTD, which has a close relationship with 18F-AV-1451 binding, taken in this study to represent a marker of either FTLD-tau or FTLD-TDP-43 neuropathology. The gene discussed is MAPT; the disease is frontotemporal dementia.